AIGH Capital Management Discloses 5.9% Stake in Cognition Therapeutics
Ticker: CGTX · Form: SC 13G/A · Filed: Feb 7, 2024 · CIK: 1455365
| Field | Detail |
|---|---|
| Company | Cognition Therapeutics INC (CGTX) |
| Form Type | SC 13G/A |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, amendment, biotech
TL;DR
**AIGH Capital Management owns 5.9% of Cognition Therapeutics, a bullish signal.**
AI Summary
AIGH Capital Management, LLC, a Maryland-based entity, filed an amended Schedule 13G/A on February 7, 2024, disclosing its beneficial ownership in Cognition Therapeutics, Inc. As of January 30, 2024, AIGH Capital Management holds 1,448,270 Common Shares, representing 5.9% of the company's outstanding shares. This filing indicates a significant, though not controlling, stake by an institutional investor, which could signal confidence in the company's future or a strategic investment, potentially influencing other investors' perceptions of the stock.
Why It Matters
This filing shows a notable institutional investor, AIGH Capital Management, maintains a significant stake in Cognition Therapeutics, which can be seen as a vote of confidence and might attract other investors.
Risk Assessment
Risk Level: low — This filing indicates an institutional investor's position, which generally adds stability and transparency, posing low risk.
Analyst Insight
A smart investor would view AIGH Capital Management's 5.9% stake as a positive signal, suggesting institutional confidence in Cognition Therapeutics, and might consider further research into the company's fundamentals and future prospects.
Key Numbers
- 1,448,270 — Common Shares (total shares beneficially owned by AIGH Capital Management, LLC)
- 5.9% — Percentage of Class (percentage of Cognition Therapeutics, Inc.'s Common Shares owned by AIGH Capital Management, LLC)
Key Players & Entities
- AIGH Capital Management, LLC (company) — the reporting person beneficially owning shares of Cognition Therapeutics, Inc.
- Cognition Therapeutics, Inc. (company) — the issuer of the securities being reported on
- Orin Hirschman (person) — the individual associated with the filing entity
- Maryland (company) — place of organization for AIGH Capital Management, LLC
- January 30, 2024 (date) — date of event requiring the filing
- February 7, 2024 (date) — date the filing was made
Forward-Looking Statements
- AIGH Capital Management, LLC will maintain its significant stake in Cognition Therapeutics, Inc. for the foreseeable future. (AIGH Capital Management, LLC) — medium confidence, target: 2025-02-07
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person is AIGH Capital Management, LLC, as stated in Item 1 of the cover page and the filing details.
What is the CUSIP number for Cognition Therapeutics, Inc.'s Common Shares?
The CUSIP number for Cognition Therapeutics, Inc.'s Common Shares is 19243B102, as listed on the cover page of the filing.
How many shares does AIGH Capital Management, LLC beneficially own in Cognition Therapeutics, Inc.?
AIGH Capital Management, LLC beneficially owns 1,448,270 Common Shares, as reported in Row 9 of the cover page.
What percentage of Cognition Therapeutics, Inc.'s Common Shares does AIGH Capital Management, LLC own?
AIGH Capital Management, LLC owns 5.9% of Cognition Therapeutics, Inc.'s Common Shares, as indicated in Row 13 of the cover page.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was January 30, 2024, as specified on the first page of the Schedule 13G/A.
Filing Stats: 1,140 words · 5 min read · ~4 pages · Grade level 8.1 · Accepted 2024-02-07 19:01:44
Filing Documents
- formsc13ga.htm (SC 13G/A) — 84KB
- 0001493152-24-005342.txt ( ) — 85KB
(a) above and Item 4 of each cover page
Item 2(a) above and Item 4 of each cover page. (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 19243B102 ITEM 3: IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________. ITEM 4: OWNERSHIP. See Item s 5,6,7,8 and 9 of each cover page. ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON